CeftazidimeThird Party Manufacturing in India

Ceftazidime works by binding to and inactivating penicillin-binding proteins (PBPs) located within the bacterial cell membrane. These proteins are critical enzymes responsible for the final transpeptidation step of peptidoglycan synthesis in the bacterial cell wall.

By blocking these key enzymes, Ceftazidime prevents the proper cross-linking of the peptidoglycan layers, which are essential for maintaining the structural integrity of the cell wall. This disruption leads to a weakened cell wall, causing bacterial swelling, membrane instability, and eventual osmotic lysis and cell death. It exhibits bactericidal action against a wide variety of Gram-negative and Gram-positive bacterial pathogens.

Unlike earlier generations of cephalosporins, Ceftazidime displays high resistance to degradation by most beta-lactamase enzymes, especially those produced by Gram-negative organisms like Pseudomonas aeruginosa. It is widely used in hospital settings to treat serious, complicated infections in both adult and pediatric populations.

Therapeutic Uses

Ceftazidime is prescribed for the treatment of:

• Pseudomonas Infections: Highly effective against infections caused by Pseudomonas aeruginosa.
• Severe Pneumonia: Manages nosocomial and community-acquired lower respiratory tract infections.
• Complicated Urinary Tract Infections: Resolves complex infections of the bladder and kidneys.
• Meningitis: Treats bacterial infections affecting the membranes of the brain and spinal cord.
• Intra-abdominal Infections: Used for treating peritonitis and gallbladder infections.
• Bone and Joint Infections: Resolves bacterial osteomyelitis and septic arthritis.

Why Partner with a WHO-GMP Ceftazidime Manufacturer

Ceftazidime third party manufacturing in India represents a major sector in sterile injectable drug production. As a widely utilized clinical antibiotic included on the WHO Model List of Essential Medicines, Ceftazidime maintains a high and continuous global demand from hospitals, government supply tenders, and private clinical networks.

By choosing a WHO-GMP certified manufacturer, pharmaceutical companies can ensure access to specialized sterile powder-filling facilities. This guarantees the highest level of product purity, minimal batch variation, and complete compliance with domestic IP and international USP/BP grade requirements, helping brands capture market share in both PCD franchise distribution and export markets.